The Omicron variant of the coronavirus does not have a negative effect on cardiovascular health in young adults who have been vaccinated, a small study suggests. Additionally, women should not delay routine mammograms after receiving a COVID-19 mRNA vaccine, experts now say.
Novo Nordisk receives FDA approval of higher-dose Ozempic 2 mg providing increased glycemic control for adults with type 2 diabetes
Approvals, Blockbusters, Blood Sugar Levels, Cardiovascular Events, Deaths, FDA/Regulatory, Glucagon-Like Peptide-1 (GLP-1) Analogs, Heart Attacks, Heart Diseases, New Doses, Stroke, Therapeutics, Type 1 DiabetesThe U.S. Food and Drug Administration approved a 2 mg dose of Novo Nordisk’s Ozempic (semaglutide) injection, a once-weekly glucagon-like peptide-1 (GLP-1) analog indicated along with diet and exercise to improve blood sugar in adults with type 2 diabetes and to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes and known heart disease.
New Jersey-based Eagle Pharmaceuticals, a company geared towards pharmaceutical hospital sales, finalized terms to acquire Acacia Pharma.
Google announced on March 24 the latest plans for using smartphones to monitor health, saying the company would test whether capturing heart sounds and eyeball images could help people identify issues from home.
Studies Suggest Links Between COVID-19 and Diabetes, Pregnancy Risks and Dementia
Clinical Trials, Coronavirus Disease 2019 (COVID-19), COVID-19 Studies, Dementia, Diabetes, Heart Problems, JAMA Internal Medicine, Nature Medicine, Neurological Conditions, Pregnancies, R&D, The Lancet Diabetes & Endocrinology, Type 2 Diabetes, University of Iowa, University of Rochester Medical CenterThe most obvious risks from COVID-19 are hospitalization and death. But study after study shows the disease comes with an increased risk of a number of health problems, including diabetes.
Two months after receiving a gene-edited pig heart, David Bennett Sr. passed away at the age of 57 years.
Omicron infections contagious for at least 6 days; Takeda drug shows promise as COVID treatment
Coronavirus Disease 2019 (COVID-19), COVID-19 Infections, COVID-19 Vaccinations, Delta Variant (B.1.617.2; India), Heart, Hospitalized COVID-19 Patients, Massachusetts General Hospital, Omicron (B.1.1.529) (South Africa), Omicron BA.2, R&D, TakedaPatients infected with the Omicron variant of SARS-CoV-2 remain contagious for just as long as patients infected with earlier variants, according to a small study. Additionally, researchers said a drug used to treat a blood vessel condition called angioedema showed promise as a treatment for COVID-19 in lab experiments.
Extending the interval between the first two doses of the most widely used COVID-19 vaccines in the country to eight weeks for young men can reduce the rare risk of heart inflammation, U.S. health officials said.
COVID Update: Revisiting the Lab-Leak Theory and Under 5 Vaccination
Beijing, CDC, Children, China, Clinical Data, Clinical Trials, Covid-19 Data, COVID-19 Infections, COVID-19 Origins, COVID-19 Vaccinations, Emergency Use Authorization (EUA), GlaxoSmithKline, Heart Disease, Heart Problems, Janssen, Johnson & Johnson, Neutralizing Antibodies, New England Journal of Medicine, Omicron (B.1.1.529) (South Africa), Omicron BA.2, R&D, Scripps Research Institute, Vir BiotechnologyJane Qiu, a freelance science writer based in Beijing, published an overview of her efforts to investigate the lab-leak theory for the origin of COVID-19. In another update, the FDA’s Vaccines and Related Biological Products Advisory Committee is scheduled to meet on February 15 to discuss an amended Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine for children 6 months through 4 years of age.
U.S. health officials on Feb. 4 said they are considering lengthening the recommended interval between the first two doses of the most widely used COVID-19 vaccines to eight weeks to lower the risk of heart inflammation and improve their effectiveness.